EUVIMEDEUVIMED entdecken
Crossref

Insulin Pump Therapy: Yesterday, Today and Tomorrow

David Bell, Edison Goncalves

Frontiers in Medical Case Reports · 2021

DOI: 10.47746/fmcr.2021.2206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medical Case Reports, 2021. Verfasst von David Bell und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Historically, CSII therapy counteracted the peaking and short action of a long-acting human insulin through short-acting insulin in pumps obtaining stable and steady insulin levels between meals. As better short-acting insulins became available, the efficacy of CSII improved. Recently, the availability of long-acting and “peakless” insulins reduced the need for CSII. However, with the availability of accurate sensors utilized in a closed loop algorithm in combination with CSII has resulted in resurgence of CSII use. In the future the ability to utilize glucagon or even pramlintide infusions in combination with insulin infusion may result in even better glycemic control and greater use of CSII.

Zitieren

APA

Bell, D., & Goncalves, E. (2021). Insulin Pump Therapy: Yesterday, Today and Tomorrow. Frontiers in Medical Case Reports. https://doi.org/10.47746/fmcr.2021.2206

Vancouver

Bell D, Goncalves E. Insulin Pump Therapy: Yesterday, Today and Tomorrow. Frontiers in Medical Case Reports. 2021. doi:10.47746/fmcr.2021.2206

BibTeX
@article{Bell2021,
  author = {Bell, David and Goncalves, Edison},
  title = {Insulin Pump Therapy: Yesterday, Today and Tomorrow},
  journal = {Frontiers in Medical Case Reports},
  year = {2021},
  doi = {10.47746/fmcr.2021.2206}
}
Kostenlos starten →